JANONE INC (JAN) Stock Price & Overview
NASDAQ:JAN • US47089W1045
Current stock price
The current stock price of JAN is 23.6 USD. Today JAN is up by 1002.8%. In the past month the price decreased by -13.23%. In the past year, price increased by 120.79%.
JAN Key Statistics
- Market Cap
- 275.412M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -3.97
- Dividend Yield
- N/A
JAN Stock Performance
JAN Stock Chart
JAN Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to JAN. When comparing the yearly performance of all stocks, JAN is one of the better performing stocks in the market, outperforming 94.9% of all stocks.
JAN Earnings
JAN Forecast & Estimates
JAN Groups
Sector & Classification
JAN Financial Highlights
Over the last trailing twelve months JAN reported a non-GAAP Earnings per Share(EPS) of -3.97. The EPS decreased by -163.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -107.89% | ||
| ROE | -262.72% | ||
| Debt/Equity | 0.14 |
JAN Ownership
JAN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.94 | 865.533B | ||
| JNJ | JOHNSON & JOHNSON | 20.21 | 572.592B | ||
| MRK | MERCK & CO. INC. | 22.06 | 282.347B | ||
| PFE | PFIZER INC | 9.03 | 155.861B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.08 | 118.339B | ||
| ZTS | ZOETIS INC | 16.34 | 48.963B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.78 | 26.264B | ||
| VTRS | VIATRIS INC | 5.26 | 15.544B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.8 | 12.489B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.127B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.974B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.21B | ||
| LGND | LIGAND PHARMACEUTICALS | 24.12 | 4.197B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About JAN
Company Profile
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2006-02-22. Through its fintech activities, it provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, it offers two main platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Through its biotech activities, it is developing solutions intended to help end the opioid crisis.
Company Info
IPO: 2006-02-22
JANONE INC
325 E Warm Springs Rd Ste 102
Las Vegas NEVADA 89119 US
CEO: Tony Isaac
Employees: 5
Phone: 17029975968
JANONE INC / JAN FAQ
Can you describe the business of JANONE INC?
JanOne, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of pain and addiction. The company is headquartered in Las Vegas, Nevada and currently employs 5 full-time employees. The company went IPO on 2006-02-22. Through its fintech activities, it provides blockchain-powered technologies to enable a migration to a new global financial paradigm for the trading, clearing, settlement, payment, and custodianship of digital instruments. Through its fintech subsidiaries, it offers two main platforms to its customers: ALT5 Pay and ALT5 Prime. ALT5 Pay is a cryptocurrency payment gateway that enables registered and approved global merchants to accept and make cryptocurrency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Through its biotech activities, it is developing solutions intended to help end the opioid crisis.
What is the current price of JAN stock?
The current stock price of JAN is 23.6 USD. The price increased by 1002.8% in the last trading session.
Does JANONE INC pay dividends?
JAN does not pay a dividend.
What is the ChartMill technical and fundamental rating of JAN stock?
JAN has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is JANONE INC worth?
JANONE INC (JAN) has a market capitalization of 275.41M USD. This makes JAN a Micro Cap stock.
When does JANONE INC (JAN) report earnings?
JANONE INC (JAN) will report earnings on 2024-08-15, after the market close.